Documents | EPAD | European Prevention of Alzheimer's Dementia Consortium

Name	Downloads	Version	Owner	Last Modified	Rating
Name	Downloads	Version	Owner	Last Modified	Rating
Publications
Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer’s Dementia (EPAD) V500.0 Cohort » Multimorbidity and Cerebrospinal Fluid Amyloid_2019.pdf File Options Download Description Preview Other Versions Goto Post	425 downloads	1.0	EPAD Administrator3	16-08-2019
At, with and beyond risk: expectations of living with the possibility of future dementia » At with and beyond risk_2018.pdf File Options Download Description Preview Other Versions Goto Post	684 downloads	1.0	EPAD Administrator3	16-04-2018
Brain Amyloid Pathology and Cognitive Function Alzheimer Disease Without Dementia? » jama_2017.pdf File Options Download Description Preview Other Versions Goto Post	1126 downloads	1.0.1	EPAD Administrator3	13-06-2017
Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Results from the European Prevention of Alzheimer’s Dementia (EPAD) v500.0 Cohort » Cognitive_dispersion_2020.pdf File Options Download Description Preview Other Versions Goto Post	76 downloads	1.0	EPAD Administrator3	11-09-2020
Cognitive Functions as Predictors of Alzheimer’s Disease Biomarker Status in the European Prevention of Alzheimer’s Dementia Cohort » Cognive functions as predictors of Alzheimers disease biomarker status_2020.pdf File Options Download Description Preview Other Versions Goto Post	242 downloads	1.0	EPAD Administrator3	05-03-2020
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility » abstractritchiereview2016.pdf File Options Download Description Preview Other Versions Goto Post	1405 downloads	1.0	EPAD Administrator	01-10-2016
Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project » abstractlancetpaper2015.pdf File Options Download Description Preview Other Versions Goto Post	1348 downloads	1.0	EPAD Administrator	09-12-2015
Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion » Ethical_arguments_2018.pdf File Options Download Description Preview Other Versions Goto Post	427 downloads	1.0	EPAD Administrator3	12-12-2018
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit » abstract_ethical_challenges_2016.pdf File Options Download Description Preview Other Versions Goto Post	994 downloads	1.0	EPAD Administrator3	15-03-2016
Ethical issues in the development of readiness cohorts in Alzheimer’s disease research » abstract_ethical_issues_2017.pdf File Options Download Description Preview Other Versions Goto Post	1082 downloads	1.0	EPAD Administrator3	22-02-2017
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials » EPAD_Registry_2018.pdf File Options Download Description Preview Other Versions Goto Post	635 downloads	1.0	EPAD Administrator3	28-03-2018
European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol » EPAD LCS Study Protocol 2018.pdf File Options Download Description Preview Other Versions Goto Post	579 downloads	1.0	EPAD Administrator3	27-12-2018
Evolution and future directions for the concept of mild cognitive impairment » evolution_future_directions_2017.pdf File Options Download Description Preview Other Versions Goto Post	693 downloads	1.0	EPAD Administrator3	13-12-2017
Involving research participants in a pan-European research initiative: the EPAD participant panel experience » EPAD resaearhc particpant panel 2020.pdf File Options Download Description Preview Other Versions Goto Post	26 downloads	1.1	EPAD Administrator3	27-10-2020
Medial temporal lobe atrophy and posterior atrophy scales normative values » Medical_temporal_2019.pdf File Options Download Description Preview Other Versions Goto Post	330 downloads	1.0	EPAD Administrator3	15-07-2019
Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease » Multi study validation_2019.pdf File Options Download Description Preview Other Versions Goto Post	332 downloads	1.0	EPAD Administrator3	23-07-2019
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context » Personal utility of Alzheimer’s disease-related biomarker testing in the research context.pdf File Options Download Description Preview Other Versions Goto Post	636 downloads	1.0	EPAD Administrator3	29-08-2018
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals » Biomarker_2018.pdf File Options Download Description Preview Other Versions Goto Post	560 downloads	1.0	EPAD Administrator3	20-02-2018
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies » Precise prevention of Alzheimer's and other dementias 2020.pdf File Options Download Description Preview Other Versions Goto Post	13 downloads	1.0	EPAD Administrator3	20-08-2020
Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study » Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals1.pdf File Options Download Description Preview Other Versions Goto Post	17 downloads	1.0	EPAD Administrator3	09-11-2020
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings » Prescreening for EPAD trial-ready cohort_2020.pdf File Options Download Description Preview Other Versions Goto Post	241 downloads	1.0	EPAD Administrator3	06-01-2020
Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review » abstractrichardreview2016.pdf File Options Download Description Preview Other Versions Goto Post	1072 downloads	1.0	EPAD Administrator	10-11-2016
Re-aligning scientific and lay narratives of Alzheimer's disease » Re-aligning scientific and lay narratives of Alzheimer's disease_2019.pdf File Options Download Description Preview Other Versions Goto Post	268 downloads	1.0	EPAD Administrator3	01-10-2019
Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project » abstractritchierecommendations2016.pdf File Options Download Description Preview Other Versions Goto Post	1213 downloads	1.0	EPAD Administrator	01-10-2016
Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes » Research participants as collaborators_2018.pdf File Options Download Description Preview Other Versions Goto Post	569 downloads	1.0	EPAD Administrator3	29-10-2018
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions » Secondary prevention_2018.pdf File Options Download Description Preview Other Versions Goto Post	572 downloads	1.0	EPAD Administrator3	30-10-2018
The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0 » v500.0_baseline data release_2019.pdf File Options Download Description Preview Other Versions Goto Post	279 downloads	1.0	EPAD Administrator3	26-11-2019
The Rationale Behind the New Alzheimer’s Disease Conceptualization: Lessons Learned During the Last Decades » Rationale_Behind_New_Alzheimer's_Disease_Conceptualization_2018.pdf File Options Download Description Preview Other Versions Goto Post	606 downloads	1.0	EPAD Administrator3	13-03-2018

EPAD

@IMI_EPAD

The final dataset for the @IMI_EPAD Longitudinal Cohort Study is now available for all researchers. We've called it Version.IMI (v.imi) as it represents all the data collected and processed during the @IMI_JU period of EPAD. #milestone #achievement ep-ad.org/2020/11/30/the… pic.twitter.com/injaLGbuX7

2:36 pm · 2020-11-30

EPAD

@IMI_EPAD

"The rich @IMI_EPAD dataset is available to the neurodegenerative disease #research community for analysis." Have a look on the #CTAD20 conference coverage published on the @alzforum ⤵️ alzforum.org/news/conferenc…

8:04 am · 2020-11-30

EPAD

@IMI_EPAD

.@IMI_EPAD offers a way of accessing the data, samples and image data collected during the EPAD Longitudinal Cohort Study (LCS) to academic researchers, institutions and companies from all over the world. How to apply? Visit the EPAD website ⤵️ ep-ad.org/open-access-da…

8:57 am · 2020-11-27

EPAD

@IMI_EPAD

The EPAD Bioresource consists of over 100,000 samples. We’ve sent out our first batch of samples to an external partner @alchemabtx. We’re excited that the Longitudinal Cohort Study continues to be an important resource which generates new #data for #Alzheimer’s disease #research pic.twitter.com/ZJ2R0KBehx

8:54 am · 2020-11-27

EPAD

@IMI_EPAD

Learn more about the #Alzheimer's disease Workbench and how @AlzData is advancing #research through collaboration and #openaccess to #data alzheimersdata.org

1:05 pm · 2020-11-24